DEF 14A

Company

FILANA THERAPEUTICS, INC.

Filed

April 14, 2016

Period of Report

April 13, 2016

Accession Number

0001069530-16-000054

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →